CD26-positive cells from colon cancer exhibit metastatic abilities (36), and the results from the current study demonstrated, for the first time, their presence in the blood circulation of colorectal cancer patients and the correlation with patient prognosis for cancer recurrence. Here, DPP4 is linked to cancer.